HCPLive
The ACG Annual Scientific Meeting and Postgraduate Course

ACG 2011: Challenging Issues in Ulcerative Colitis Therapy - Adherence and Quality of Life [Podcast]

Raymond Cross, MD, associate professor of medicine and director of the inflammatory bowel disease program at the University of Maryland School of Medicine, describes challenges with adherence to therapy and discusses methods to improve quality of life.


Most Popular

Recommended Reading

Tenofovir alafenamide, which results in 90% lower circulating plasma tenofovir than standard tenofovir disoproxil fumarate, is associated with similar virologic response rates as the standard regimen, but with an improved safety profile.
Combination treatment with daclatasvir and asunaprevir plus interferon/ribavirin had high success rates in a 24-week clinical trial for treatment of hepatitis C in patients coninfected with HIV.
An interferon/ribavirin-free pill that combines two drugs to treat patients with certain genotypes of hepatitis C who are also infected with HIV was found to be highly effective in a 12-week trial, clearing the hepatitis C virus from almost all the patients involved.
Novel second-generation HIV-1 maturation inhibitor shows favorable antiviral activity and safety profile in HIV-1, subtype B-infected subjects
$vacMongoViewPlus$ $vAR$